BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25407567)

  • 1. The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.
    Harper BW; Aldrich-Wright JR
    Dalton Trans; 2015 Jan; 44(1):87-96. PubMed ID: 25407567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Park JJ; Pratt JM; Tweedale L; Kelland LR
    J Med Chem; 1999 Aug; 42(16):3167-74. PubMed ID: 10447962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.
    Rakić GM; Grgurić-Šipka S; Kaluđerović GN; Bette M; Filipović L; Aranđelović S; Radulović S; Tešić ZLj
    Eur J Med Chem; 2012 Sep; 55():214-9. PubMed ID: 22858225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4'-substituted-2,2':6',2″-terpyridine ligands.
    Qin QP; Wang ZF; Wang SL; Luo DM; Zou BQ; Yao PF; Tan MX; Liang H
    Eur J Med Chem; 2019 May; 170():195-202. PubMed ID: 30897397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
    Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
    Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
    Wagner G; Marchant A; Sayer J
    Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N; Kelland LR; Roberts JD; Van Beusichem M
    Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and antitumor activity of new chloroethylamine platinum complexes.
    Khokhar AR; Xu Q; Newman RA; Kido Y; Siddik ZH
    J Inorg Biochem; 1992 Feb; 45(3):211-9. PubMed ID: 1634893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.
    Zhang J; Li L; Ji X; Sun J; Wang L; Zhang Y
    Eur J Med Chem; 2010 Jun; 45(6):2634-7. PubMed ID: 20153562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
    Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
    Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New steroidal 7-azaindole platinum(II) antitumor complexes.
    Zamora A; Rodríguez V; Cutillas N; Yellol GS; Espinosa A; Samper KG; Capdevila M; Palacios O; Ruiz J
    J Inorg Biochem; 2013 Nov; 128():48-56. PubMed ID: 23932925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
    Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(ii) complexes showing high cytotoxicity toward A2780 ovarian carcinoma cells.
    Choroba K; Machura B; Raposo LR; Małecki JG; Kula S; Pająk M; Erfurt K; Maroń AM; Fernandes AR
    Dalton Trans; 2019 Sep; 48(34):13081-13093. PubMed ID: 31411239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.